- 36.3k views
Assessing Lymphoma Complications
Lymphoma is a malignancy that affects white blood cells (lymphocytes) in the lymphatic system, which is part of the body's immune system. The lymphatic system consists of a network of small channels comparable to blood arteries that transport fluid (called lymph), lymph nodes (also known as glands), bone marrow, and various organs, including the spleen, all of which contain lymphocytes. Lymphoma is classified into two types: Hodgkin (HL) and non-Hodgkin (NHL), each with its own set of subgroups. Hodgkin lymphoma, commonly known as Hodgkin's disease, is significantly less prevalent than non-Hodgkin lymphoma. Individual lymphomas differ in their behavior, spread, and response to treatment. Hodgkin lymphoma is identified by the presence of an aberrant cell known as a Reed-Sternberg cell. When it is absent, the malignancy is characterized as non-Hodgkin.
About the Speaker
Dr. Jyothi Jonnadula
Consultant Radiation Oncology, Renova Century Hospitals, Hyderbad
Dr. Jyothi Jonnadula, Consultant Radiation Oncology, Renova Century Hospitals, Hyderbad
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Molecular and Genetic studies in Gynaecological Malignancies
Molecular and genetic studies in gynecological malignancies have revolutionized diagnostics, prognostics, and targeted therapies. Advances in genomic sequencing have identified key mutations in ovarian (BRCA1/2, TP53), endometrial (PTEN, MSI), and cervical cancers (HPV integration, PIK3CA). These findings aid in precision medicine, guiding individualized treatments like PARP inhibitors for BRCA-mutated ovarian cancer. Epigenetic modifications, including DNA methylation and miRNA regulation, further influence tumor progression and therapeutic response. Emerging technologies like liquid biopsies and multi-omics approaches enhance early detection and monitoring. Understanding these molecular pathways is crucial for developing novel therapies and improving survival outcomes in gynecological malignancies.
AI in Enhancing Emergency Care
AI is revolutionizing emergency care by enabling faster, more accurate decision-making. It helps triage patients efficiently, analyze medical data in real-time, and predict outcomes based on historical data, which can prioritize critical cases. AI-powered tools, like diagnostic imaging analysis and predictive algorithms, assist doctors in identifying conditions such as strokes or heart attacks earlier, improving survival rates. Additionally, AI enhances resource allocation and staff management in emergency departments, optimizing response times and reducing workload for healthcare providers.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Jyothi Jonnadula's Talks on Assimilate
- 30th -Sep -2024, TIME : 5:00PM TO 6:00 PM
- 0
Lymphoma is a malignancy that affects white blood cells (lymphocytes) in the lymphatic system, which is part of the body's immune system. The lymphatic system consists of a network of small channels comparable to blood arteries that transport fluid (called lymph), lymph nodes (also known as glands), bone marrow, and various organs, including the spleen, all of which contain lymphocytes. Lymphoma is classified into two types: Hodgkin (HL) and non-Hodgkin (NHL), each with its own set of subgroups. Hodgkin lymphoma, commonly known as Hodgkin's disease, is significantly less prevalent than non-Hodgkin lymphoma. Individual lymphomas differ in their behavior, spread, and response to treatment. Hodgkin lymphoma is identified by the presence of an aberrant cell known as a Reed-Sternberg cell. When it is absent, the malignancy is characterized as non-Hodgkin.